MBOT Stock Summary and Trading Ideas (Microbot Medical | NASDAQ:MBOT)

Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.

Microbot Medical trades on the NASDAQ stock market under the symbol MBOT.

As of December 16, 2025, MBOT stock price climbed to $2.24 with 1,007,390 million shares trading.

MBOT has a beta of 1.45, meaning it tends to be more sensitive to market movements. MBOT has a correlation of 0.05 to the broad based SPY ETF.

MBOT has a market cap of $150.43 million. This is considered a Micro Cap stock.

Last quarter Microbot Medical reported $0 in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-5 million and missed earnings estimates by -$.04.

In the last 3 years, MBOT traded as high as $4.67 and as low as $.82.

The top ETF exchange traded funds that MBOT belongs to (by Net Assets): VTI, VXF, IWC.

MBOT has outperformed the market in the last year with a return of +124.0%, while the SPY ETF gained +13.5%. However, in the most recent history, MBOT shares have underperformed the stock market with its stock returning -34.5% in the last 3 month period and -0.9% for the last 2 week period, while SPY has returned +3.0% and -0.2%, respectively.

MBOT support price is $2.08 and resistance is $2.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MBOT shares will trade within this expected range on the day.